Literature DB >> 20635460

Interaction between warfarin and the herbal product Shengmai-yin: a case report of intracerebral hematoma.

Qun Su1, Yuhong Li.   

Abstract

A 71-year-old man was stable on warfarin (2.25 mg daily) therapy with an international normalized ratio (INR) of 1.8-2.2 after a heart valve replacement surgery. Recently, he consumed the liquid-like herbal product called shengmai-yin (10 mL daily) against medical advice. Seven days after the daily consumption of shengmai-yin, he was admitted to the intensive care unit because of consciousness disturbance [Glasgow Coma Scale (GCS) score 7] with an INR of 5.08. Head computed topography revealed intracerebral hematoma in the left temporoparietal region. Both warfarin therapy and the herbal product were withdrawn. At the same time, therapy with intravenous vitamin K1 40 mg was started. On the second day of admission, craniectomy was performed to remove the intacerebral hematoma under general anesthesia. He remained confused and restless for 2 days, but then showed progressive recovery in the consciousness level as well as motor and verbal functions. Shengmai-yin contains herbal ingredients that can interact with warfarin. The Drug Interaction Probability Scale (DIPS) indicated that warfarin and shengmai-yin were highly probable causes of intracerebral hematoma. Patients on warfarin therapy should be discouraged from taking herbal medicines, especially preparations that are already known to have antiplatelet and antithrombotic effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20635460      PMCID: PMC2908877          DOI: 10.3349/ymj.2010.51.5.793

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  19 in total

1.  Proposal for a new tool to evaluate drug interaction cases.

Authors:  John R Horn; Philip D Hansten; Lingtak-Neander Chan
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

2.  [Effects of shengmai for injection on cardiogenic shock].

Authors:  Xiao-Fei Ding; Guang Chen; Yu-Lan Liu
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2007-11

3.  Prevention and repair of cerebral ischemia-reperfusion injury by Chinese herbal medicine, shengmai san, in rats.

Authors:  W Xuejiang; T Magara; T Konishi
Journal:  Free Radic Res       Date:  1999-11

4.  Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats.

Authors:  M Zhu; K W Chan; L S Ng; Q Chang; S Chang; R C Li
Journal:  J Pharm Pharmacol       Date:  1999-02       Impact factor: 3.765

5.  Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach.

Authors:  Xuemin Jiang; Elaine Y L Blair; Andrew J McLachlan
Journal:  J Clin Pharmacol       Date:  2006-11       Impact factor: 3.126

6.  Antithrombotic and antiplatelet activities of Korean red ginseng extract.

Authors:  Yong-Ri Jin; Ji Yeon Yu; Jung-Jin Lee; Soon-Hyang You; Jin-Ho Chung; Ji-Yoon Noh; Ji-Hyun Im; Xiang-Hua Han; Tack-Joong Kim; Kyeong-Soeb Shin; Jae Joon Wee; Yeo-Pyo Yun
Journal:  Basic Clin Pharmacol Toxicol       Date:  2007-03       Impact factor: 4.080

7.  Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats.

Authors:  Ying Mu; Jinnan Zhang; Shimin Zhang; Hong-Hao Zhou; David Toma; Songrong Ren; Leaf Huang; Maria Yaramus; Andrew Baum; Raman Venkataramanan; Wen Xie
Journal:  J Pharmacol Exp Ther       Date:  2005-11-02       Impact factor: 4.030

8.  Chinese herbal medicine, Shengmai San, is effective for improving circulatory shock and oxidative damage in the brain during heatstroke.

Authors:  Ning-Lu Wang; Yann-Lin Liou; Mao-Tsun Lin; Chia-Li Lin; Cheng-Kuei Chang
Journal:  J Pharmacol Sci       Date:  2005-02-05       Impact factor: 3.337

9.  Interaction between warfarin and Panax ginseng in ischemic stroke patients.

Authors:  Sang-Hun Lee; Young-Min Ahn; Se-Young Ahn; Ho-Kyung Doo; Byung-Cheol Lee
Journal:  J Altern Complement Med       Date:  2008-07       Impact factor: 2.579

10.  Endoscopic management of hypertensive intraventricular haemorrhage with obstructive hydrocephalus.

Authors:  Yad Ram Yadav; Gaurav Mukerji; Ravikiran Shenoy; Abhijeet Basoor; Gaurav Jain; Adam Nelson
Journal:  BMC Neurol       Date:  2007-01-04       Impact factor: 2.474

View more
  4 in total

Review 1.  Critical evaluation of causality assessment of herb-drug interactions in patients.

Authors:  Charles Awortwe; Memela Makiwane; Helmuth Reuter; Christo Muller; Johan Louw; Bernd Rosenkranz
Journal:  Br J Clin Pharmacol       Date:  2018-01-29       Impact factor: 4.335

Review 2.  A review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect.

Authors:  Tung-Ting Sham; Chi-On Chan; You-Hua Wang; Jian-Mei Yang; Daniel Kam-Wah Mok; Shun-Wan Chan
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

Review 3.  A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.

Authors:  Hsin-Hui Tsai; Hsiang-Wen Lin; Ying-Hung Lu; Yi-Ling Chen; Gail B Mahady
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

4.  The Inhibition of the Components from Shengmai Injection towards UDP-Glucuronosyltransferase.

Authors:  Li-Peng Jiang; Jin Zhao; Yun-Feng Cao; Mo Hong; Dong-Xue Sun; Xiao-Yu Sun; Jun Yin; Zhi-Tu Zhu; Zhong-Ze Fang
Journal:  Evid Based Complement Alternat Med       Date:  2014-10-29       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.